Five Prime Therapeutics, Inc. discovers and develops innovative therapeutics to improve the lives of patients with serious diseases. Five Prime's comprehensive discovery platform, which encompasses virtually every medically relevant extracellular protein, positions it to explore pathways in cancer, inflammation and their intersection in immuno-oncology, an area of oncology with significant therapeutic potential and a growing focus of the company's R&D activities. Five Prime has promising product candidates in clinical and late preclinical development and has entered into strategic collaborations with leading global pharmaceutical companies.
Recent News > MORE
Upcoming and Recent Events > MORE
|Summary Toggle Tuesday, May 05, 2015 8:30 AM EDT||
|Summary Toggle Monday, September 19, 2016||
Five Prime Therapeutics Rings the NASDAQ Stock Market Opening Bell
Five Prime Therapeutics (Nasdaq: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, will visit the Nasdaq MarketSite in Times Square.
|Summary Toggle Thursday, May 04, 2017 4:30 PM EDT||